SEC Form 4 · accession 0001053369-15-000004
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry H Dash
Director
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 3:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common | Mar 5, 2015 | A | 58,475 | $0.342 | A | 1,084,229 | D |
Table II — derivative securities
No Table II lines on this filing.